Autres langues Alkem Laboratories Limited

Actions

ALKEM

INE540L01014

Produits pharmaceutiques

Marché Fermé - NSE India S.E. 13:05:07 01/10/2026			Varia. 5j.	Varia. 1 janv.
5 220,00 ^INR	+1,09 %		-1,99 %	-5,20 %

24/09	Alkem Laboratories Limited annonce la démission de Nitin Agrawal de ses fonctions de membre du personnel clé de direction et de membre de la haute direction, avec effet au 30 septembre 2026	CI
16/09	Alkem Laboratories Limited lance NeuCeno (cénobamate) pour le traitement des crises d'épilepsie à début focal chez l'adulte	CI

Autres langues

24/09	Alkem Laboratories Limited Announces Resignation of Nitin Agrawal as Chief Financial Officer
24/09	Alkem Laboratories Limited Announces Resignation of Nitin Agrawal as Key Managerial Personnel and Senior Management Personnel, Effective September 30, 2026
16/09	Alkem Laboratories Limited Launches Neuceno for the Treatment of Partial-Onset Seizures in Adult Patients
15/09	Alkem Laboratories Limited Announces Appointment of Shubhadeep Sinha to Senior Management Position, Effective September 15, 2026
08/09	Alkem Laboratories Limited Launches Renocia Exo, India?s First Patented Ginsenoside Exosome-Based Hair Growth Serum
14/08	Alkem Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
03/08	Alkem Laboratories Limited Announces Appointment of Rajpal Singh Rana to Senior Management Position, Effective August 03, 2026
23/07	Alkem Laboratories Limited Announces Resignation of Resignation of Jitendra Singh Huda as Senior Management Personnel, Effective from July 23, 2026
02/06	Alkem Laboratories Limited Launches Semaglutide in Single-Shot Pre-Filled Syringes At Price Starting Inr 350
02/06	Alkem Laboratories Shows Strong Moves But Weak Follow-Through
28/05	Alkem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
28/05	Alkem Laboratories Limited Recommends Final Dividend for Financial Year Ended 31 March, 2026, Payable on and from 01 September, 2026
18/05	Alkem Laboratories Limited Appoints Chanakya Misra to Senior Management Position, Effective May 18, 2026
08/05	Alkem Labs says US FDA conducts unannounced inspection at Alkem CRO facility
08/05	Alkem Laboratories Limited Receives No Form 483 After US FDA Inspection At CRO Facility Located At Taloja
05/05	Alkem Labs says Order-In-Appeal drops tax demand of 696.6 million rupees
04/05	Alkem Laboratories Gets 7 Observations from US FDA After Daman Plant Inspection
24/04	Alkem Labs gets tax demand of 3.3 billion rupees
24/04	Alkem Laboratories Limited Announces Resignation of Vikas Gupta as Key Managerial Personnel, Effective June 30, 2026
24/04	Alkem Laboratories Limited Announces Resignation of Chief Executive Officer Vikas Gupta, Effective June 30, 2026
13/04	Alkem Pharma Trading FZCO announced that it has received AED 3.67 million in funding from Alkem Laboratories Limited
07/04	Alkem Laboratories Limited Launches A to Z Daily Multivitamin Supplement for Adults
02/04	Alkem Laboratories Gets Board Nod to Boost Investment in New Factory
02/04	Alkem Labs says board approves increase investment to up to 10.36 bln rupees from 5.33 bln rupees for Ujjain facility
30/03	Alkem Labs incorporates wholly owned subsidiary in Dubai Healthcare City, UAE